Aspirin Improves Nonalcoholic Fatty Liver Disease and Atherosclerosis through Regulation of the PPAR
この論文をさがす
説明
This study is aimed at elucidating how aspirin could systemically and simultaneously normalize nonalcoholic fatty liver disease (NAFLD) and atherosclerosis through both
収録刊行物
-
- BioMed research international
-
BioMed research international 2020 2019-10-27
- Tweet
キーワード
- Male
- Aspirin
- Hep G2 Cells
- AMP-Activated Protein Kinases
- Atherosclerosis
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
- Mice
- RAW 264.7 Cells
- Non-alcoholic Fatty Liver Disease
- Human Umbilical Vein Endothelial Cells
- Animals
- Humans
- PPAR delta
- Rabbits
- Dyslipidemias
- Signal Transduction